Biotechnology company BioNTech SE (NASDAQ: BNTX) recently announced that it has entered into an agreement with clinical-stage immuno-oncology company Crescendo Biologics Ltd. to develop novel ...
CAMBRIDGE, England--(BUSINESS WIRE)--Crescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, today announces that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results